These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35324536)

  • 21. First results of clinical diagnostic analysis of post-COVID peripheral neuropathy.
    Avetisov SE; Surnina ZV; Ahmedzhanova LT; Georgiev S
    Vestn Oftalmol; 2021; 137(4):58-64. PubMed ID: 34410058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection.
    Saif DS; Ibrahem RA; Eltabl MA
    Int J Rheum Dis; 2022 Nov; 25(11):1246-1253. PubMed ID: 35915515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States.
    Katz D; Bateman BT; Kjaer K; Turner DP; Spence NZ; Habib AS; George RB; Toledano RD; Grant G; Madden HE; Butwick AJ; Lynde G; Minehart RD; Beilin Y; Houle TT; Sharpe EE; Kodali B; Bharadwaj S; Farber MK; Palanisamy A; Prabhu M; Gonzales NY; Landau R; Leffert L
    Anesth Analg; 2021 Aug; 133(2):462-473. PubMed ID: 33830956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID.
    Oaklander AL; Mills AJ; Kelley M; Toran LS; Smith B; Dalakas MC; Nath A
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35232750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY
    JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cohort study protocol to characterize the incidence and severity of neuropathic pain in patients with severe acute respiratory syndrome coronavirus 2 infection.
    Odozor CU; Roles K; Burk C; Kannampallil T; Clifford DB; Piccirillo JF; Haroutounian S
    Pain Rep; 2021; 6(1):e925. PubMed ID: 33981939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study.
    Liptak P; Duricek M; Rosolanka R; Ziacikova I; Kocan I; Uhrik P; Grendar M; Hrnciarova M; Bucova P; Galo D; Banovcin P
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):925-932. PubMed ID: 35913778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
    J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection.
    Blitz MJ; Gerber RP; Gulersen M; Shan W; Rausch AC; Prasannan L; Meirowitz N; Rochelson B
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2253-2259. PubMed ID: 34546577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis.
    Fernández-de-Las-Peñas C; Navarro-Santana M; Plaza-Manzano G; Palacios-Ceña D; Arendt-Nielsen L
    Pain; 2022 Jul; 163(7):1220-1231. PubMed ID: 34561390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients.
    Lyoo KS; Kim HM; Lee B; Che YH; Kim SJ; Song D; Hwang W; Lee S; Park JH; Na W; Yun SP; Kim YJ
    Emerg Microbes Infect; 2022 Dec; 11(1):406-411. PubMed ID: 34962444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.